AN2 Therapeutics, Inc. — SCHEDULE 13G Filings
6 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by AN2 Therapeutics, Inc. (ANTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. AN2 Therapeutics, Inc. has filed 6 SCHEDULE 13G documents with the SEC since 2021. To view all SEC filings by AN2 Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001831942-26-000014 | Mar 16, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-027730 | Mar 13, 2026 | — |
| SCHEDULE 13G | — | 0001213900-26-027660 | Mar 13, 2026 | — |
| SCHEDULE 13G | — | 0001596468-26-000004 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001596468-25-000022 | Nov 14, 2025 | — |
| SCHEDULE 13G | — | 0000935836-25-000414 | Jun 4, 2025 | — |